Vasan, Neil
Cantley, Lewis C. http://orcid.org/0000-0002-1298-7653
Article History
Accepted: 4 April 2022
First Online: 28 April 2022
Competing interests
: N.V. reports consulting activities for Novartis and is on the scientific advisory board of Heligenics. L.C.C. is a founder, shareholder and member of the scientific advisory board of Agios Pharmaceuticals, a co-founder and shareholder of Faeth Therapeutics, and a founder and former member of the scientific advisory board of Ravenna Pharmaceuticals (previously Petra Pharmaceuticals); these companies are all developing therapies for cancer. L.C.C. has also received research funding from Ravenna Pharmaceuticals.